Garcia-Doval, Carmela http://orcid.org/0000-0002-3422-9490
Schwede, Frank http://orcid.org/0000-0002-8185-3392
Berk, Christian
Rostøl, Jakob T.
Niewoehner, Ole
Tejero, Oliver
Hall, Jonathan
Marraffini, Luciano A.
Jinek, Martin http://orcid.org/0000-0002-7601-210X
Article History
Received: 24 September 2019
Accepted: 28 February 2020
First Online: 27 March 2020
Competing interests
: The authors declare the following competing interests. F.S. is General Manager of Biolog Life Science Institute GmbH & Co. KG, which synthesizes cA6 for research purposes on a commercial basis and may offer cFA6 in the future. L.A.M. is a co-founder and Scientific Advisory Board member of Intellia Therapeutics and a co-founder of Eligo Biosciences. M.J. is a co-founder and Scientific Advisory Board member of Caribou Biosciences. All other authors declare no competing interests.